tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market

Senti Biosciences (SNTI) Cash flow

61 Followers

Senti Biosciences Cash Flow

SNTI's free cash flow for Q3 2023 was $-17.42M. For the 2023 fiscal year, SNTI's free cash flow was decreased by $-67.58M and operating cash flow was $-15.56M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21
Operating Cash Flow
$ -34.79M$ -52.40M$ 3.26M$ -1.14M
Investing Cash Flow
$ -19.14M$ 30.08M$ -81.96M$ -230.00M
Financing Cash Flow
$ 1.10M$ 779.00K$ 118.55M$ 232.03M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ -25.88M$ 39.45M$ 3.26M$ 889.32K
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
----
Issuance Of Capital Stock
$ 879.00K$ 887.00K$ 879.00K$ 232.56M
Issuance Of Debt
$ -85.00K$ -108.00K$ 5.17M-
Repayment Of Debt
$ -85.00K$ -108.00K-$ -250.00K
Free Cash Flow
$ -48.85M$ -64.33M$ 3.26M$ -1.14M
Domestic Sales
----
Foreign Sales
----
Currency in USD

Senti Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis